Copyright thehindubusinessline
Time Medical International Ventures (I), a wholly owned subsidiary of Fischer Medical Ventures, has formed a strategic collaboration with globally acclaimed neurosurgeon and innovator Dr Iype Cherian for developing DRIS–iMRI Medharanya, a new variant of advanced MRI technology. A global leader in advanced medical imaging solutions, Chennai-headquartered Time Medical India specialises in the design and manufacture of cost-effective and high-performance MRI systems. The partnership will jointly develop DRIS–iMRI Medharanya, an AI-enabled portable MRI system. The technology integrates Augmented Reality, Artificial Intelligence, Machine Learning and Exoscope technologies. Designed to be an Interop MRI, the system will revolutionise complex neurosurgical procedures by providing surgeons with real-time visualisation, enabling unprecedented precision and safety, said the company. Surgical precision redefined Clinically, DRIS–iMRI Medharanya will also integrate the Extradural Parasigmoid approach to the Jugular Foramen (Ex Pa JuF), a cutting-edge surgical pathway for managing complex glomus tumours with enhanced safety and anatomical clarity. Under the collaboration, Dr Cherian will assume the role of Director – Neurosciences at Time Medical India, where he will guide the clinical innovation, neuroimaging design and translational strategy of the DRIS–iMRI Medharanya program. The partnership reflects Time Medical’s commitment to advancing imaging technology that bridges intelligence, accessibility and human-centred design, said the company. Shares of Fischer Medical Ventures were down 12 per cent at Rs 94 on Tuesday. Published on November 4, 2025
